6533b85ffe1ef96bd12c1302

RESEARCH PRODUCT

Perioperative Management of Pheochromocytoma: From a Dogmatic to a Tailored Approach

Giorgio RomanoSaverio SelvaFrancesco MinniSalvatore BuscemiGiuseppe Di BuonoLaura AlbericiRocco D’andreaClaudio RicciAntonino AgrusaLorenzo QuerciRoberto Citarrella

subject

Multivariate analysisPerioperative managementbusiness.industryalfa-blockersRAlfa‐blockersRetrospective cohort studyperioperative managementGeneral Medicinemedicine.diseaseIntensive care unitpheochromocytomaArticlelaw.inventionPheochromocytomaBlood pressurelawHemostasisAnesthesiamedicineClinical endpointAlfa‐blockerMedicinebusiness

description

Background: Perioperative management of pheochromocytoma (PCC) remains under debate. Methods: A bicentric retrospective study was conducted, including all patients who underwent laparoscopic adrenalectomy for PCC from 2000 to 2017. Patients were divided into two groups: Group 1 treated with alpha-blockade, and Group 2, without alfa-blockers. The primary end point was the major complication rate. The secondary end points were: the need for advanced intra-operative hemostasis, the admission to the intensive care unit (ICU), the length of stay (LOS), systolic (SBP), and diastolic blood pressure (DBP). Univariate and multivariate analysis was conducted. A p-value &lt

yearjournalcountryeditionlanguage
2021-08-23Journal of Clinical Medicine
10.3390/jcm10163759https://www.mdpi.com/2077-0383/10/16/3759